VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+42.63%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$906M
AUM Growth
+$906M
(-9%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-27.35%
Top 10 Holdings %
Top 10 Hldgs %
57.8%
Holding
54
New
5
Increased
4
Reduced
7
Closed
3
Top Buys
| 1 |
ALLK
Allakos
ALLK
|
$25.2M |
| 2 |
Terns Pharmaceuticals
TERN
|
$19M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$15.3M |
| 4 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$11.5M |
| 5 |
Vaxcyte
PCVX
|
$9.71M |
Top Sells
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$183M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$85.3M |
| 3 |
Harmony Biosciences
HRMY
|
$30.7M |
| 4 |
Ventyx Biosciences
VTYX
|
$19.8M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
$11.4M |
Sector Composition
| 1 | Healthcare | 97.5% |
| 2 | Materials | 2.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Harmony Biosciences
HRMY
$2.12B
| $151M | 16.63% | 3,400,261 -693,524 | -17% | -$30.7M |
|
2
Instil Bio
TIL
$182M
| $60.4M | 6.67% | 12,486,787 | – | – |
|
|
3
Ventyx Biosciences
VTYX
$171M
| $47.3M | 5.23% | 1,355,861 -565,865 | -29% | -$19.8M |
|
|
VRNA
4
Verona Pharma
VRNA
$9.16B
| $43.4M | 4.8% | 4,249,918 +1,500,000 | +55% | +$15.3M |
|
5
ALX Oncology
ALXO
$62.7M
| $40.4M | 4.46% | 4,220,048 | – | – |
|
6
Tarsus Pharmaceuticals
TARS
$2.47B
| $38.7M | 4.28% | 2,262,200 -50,168 | -2% | -$859K |
|
|
SVA
7
DELISTED
Sinovac Biotech, Ltd
SVA
| $38.2M | 4.21% | 5,900,000 | – | – |
|
8
Geron
GERN
$893M
| $35.7M | 3.94% | 15,238,095 | – | – |
|
|
9
Terns Pharmaceuticals
TERN
$609M
| $34.7M | 3.84% | 5,899,372 +3,224,239 | +121% | +$19M |
|
10
Viridian Therapeutics
VRDN
$1.5B
| $34M | 3.76% | 1,660,019 +360,019 | +28% | +$7.38M |
|
11
Cogent Biosciences
COGT
$1.69B
| $28.1M | 3.1% | 1,883,941 -37,000 | -2% | -$552K |
|
12
Relmada Therapeutics
RLMD
$37.2M
| $26.4M | 2.92% | 713,238 +7,356 | +1% | +$272K |
|
|
ALLK
13
DELISTED
Allakos
ALLK
| $25.2M | 2.78% | +4,120,134 | New | +$25.2M |
|
|
AMRS
14
DELISTED
Amyris Inc.
AMRS
| $22.6M | 2.5% | 7,750,828 -3,891,367 | -33% | -$11.4M |
|
15
KalVista Pharmaceuticals
KALV
$678M
| $22.3M | 2.46% | 1,533,559 | – | – |
|
|
KDNY
16
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $17.1M | 1.89% | 872,151 | – | – |
|
17
Ascendis Pharma
ASND
$11.8B
| $15.1M | 1.66% | 146,025 | – | – |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
| $14.7M | 1.62% | 2,937,093 | – | – |
|
19
Vera Therapeutics
VERA
$1.38B
| $14.2M | 1.57% | 666,666 | – | – |
|
20
Aclaris Therapeutics
ACRS
$209M
| $14.1M | 1.56% | 898,631 | – | – |
|
|
IMPL
21
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $14M | 1.55% | 2,884,789 | – | – |
|
|
CINC
22
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $11.5M | 1.27% | +349,237 | New | +$11.5M |
|
|
BLU
23
DELISTED
BELLUS Health Inc.
BLU
| $10.7M | 1.19% | 1,017,152 | – | – |
|
24
Legend Biotech
LEGN
$6.41B
| $9.97M | 1.1% | 244,375 | – | – |
|
|
25
Vaxcyte
PCVX
$4B
| $9.71M | 1.07% | +404,508 | New | +$9.71M |
|